Polypill for Prevention of Cardiomyopathy
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT06143566
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 200 participants
- Registry
-
NCT06143566
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06143566. Randomized; no masking; primary purpose treatment. Start 2024-03-11 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Polypill for Prevention of Cardiomyopathy
- Acronym
- PolyPreventHF
- Condition
- Type 2 Diabetes
- Condition
- High Blood Pressure
- Intervention (Drug)
- Polypill
- Intervention (Drug)
- Combined prescription of the individual medications
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct06143566- Content hash
1244a4876f1ab64043d65526a58040ec9b645adbe84db482fe91027560ca6108